{"cik":1736243,"entityName":"Acurx Pharmaceuticals,Â Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-08-13","val":10119208,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-11-11","val":10215792,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}}},"us-gaap":{"AccountsPayableAndAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Accrued Liabilities, Current","description":"Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.","units":{"USD":[{"end":"2020-12-31","val":455931,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":455931,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1918639,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":712437,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AccountsPayableAndOtherAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Other Accrued Liabilities, Current","description":"Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2021-06-30","val":97005,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":12142,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":49707,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":49707,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1750146,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":133194,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2021-06-30","val":34790591,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":38188287,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":333333,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":166666,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":508333,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":175000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":755556,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":563889,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":755556,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":3224020,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":3224020,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":17440145,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":14989628,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"Cash":{"label":"Cash","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":3175411,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":3175411,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":17095596,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":14459046,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":2483322,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2019-12-31","val":2483322,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2019Q4I"},{"end":"2020-06-30","val":1974439,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2I"},{"end":"2020-09-30","val":3406628,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3I"},{"end":"2020-12-31","val":3175411,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":3175411,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":17095596,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":14459046,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsPeriodIncreaseDecrease":{"label":"Cash and Cash Equivalents, Period Increase (Decrease)","description":"Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-508883,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":923306,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":13920185,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":11283635,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"CashFDICInsuredAmount":{"label":"Cash, FDIC Insured Amount","description":"The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.","units":{"USD":[{"end":"2021-06-30","val":17100000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":14500000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockCapitalSharesReservedForFutureIssuance":{"label":"Common Stock, Capital Shares Reserved for Future Issuance","description":"Aggregate number of common shares reserved for future issuance.","units":{"shares":[{"end":"2021-04-30","val":2000000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2021-06-30","val":0.001,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0.001,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2021-06-30","val":200000000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":200000000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2021-06-30","val":9916208,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":10126903,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2021-06-30","val":9916208,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":10126903,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2021-06-30","val":9916,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":10127,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CurrentFederalStateAndLocalTaxExpenseBenefit":{"label":"Current Federal, State and Local, Tax Expense (Benefit)","description":"Amount of current state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount":{"label":"Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount","description":"Amount of commitment made to pay deferred cash remuneration.","units":{"USD":[{"end":"2019-12-31","val":2500000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2019-12-31","val":2500000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2019Q4I"}]}},"DeferredCompensationShareBasedArrangementsLiabilityCurrent":{"label":"Deferred Compensation Share-based Arrangements, Liability, Current","description":"Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable within one year (or the operating cycle, if longer).","units":{"USD":[{"end":"2020-12-31","val":104000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":104000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-06-30","val":-0.37,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":-0.15,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2021-01-01","end":"2021-06-30","val":-0.79,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":-0.57,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"}]}},"EffectiveIncomeTaxRateContinuingOperations":{"label":"Effective Income Tax Rate Reconciliation, Percent","description":"Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"pure":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"EmployeeRelatedLiabilitiesCurrent":{"label":"Employee-related Liabilities, Current","description":"Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":317068,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":317068,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":20242,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":252117,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-06-30","val":2180640,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":7399003,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":1106992,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":512622,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":1761561,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":654569,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":5357911,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":3975488,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":8873160,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":3515250,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"IncomeTaxExpenseBenefit":{"label":"Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":{"label":"Increase (Decrease) in Accounts Payable and Accrued Liabilities","description":"The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-932547,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":-688682,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":1462708,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":256506,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"IncreaseDecreaseInPrepaidExpense":{"label":"Increase (Decrease) in Prepaid Expense","description":"The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-34733,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":-40011,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":295940,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":481973,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"IssuanceOfStockAndWarrantsForServicesOrClaims":{"label":"Issuance of Stock and Warrants for Services or Claims","description":"Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":781700,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":781700,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":916765,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":916765,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":522434,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":522434,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1918639,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":712437,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":3224020,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":3224020,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":17440145,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":14989628,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":472556,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":472556,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1918639,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":712437,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":1124163,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":3315110,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":14797132,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":14797132,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-1633046,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":-2391804,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":-876947,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":-3513497,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-1279101,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-03-31","val":-1279101,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q1"},{"start":"2020-01-01","end":"2020-06-30","val":-2192461,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":-913360,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":-913360,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-3507007,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":-1314546,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":-1474330,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-03-31","val":-1474330,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1"},{"start":"2021-01-01","end":"2021-06-30","val":-5478389,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":-4004059,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":-4004059,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-10120611,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":-4642222,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":2192461,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":913360,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":3507007,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":1314546,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":5544892,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":4070562,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":10187114,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":4642222,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":51409,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-03-31","val":51409,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2452868,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1"},{"start":"2021-01-01","end":"2021-06-30","val":2452868,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"}]}},"PrepaidExpenseCurrent":{"label":"Prepaid Expense, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":48609,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":48609,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":344549,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":530582,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceInitialPublicOffering":{"label":"Proceeds from Issuance Initial Public Offering","description":"The cash inflow associated with the amount received from entity's first offering of stock to the public.","units":{"USD":[{"end":"2021-06-29","val":17300000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2021-06-29","val":17300000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2I"},{"start":"2021-01-01","end":"2021-06-30","val":14797132,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":14797132,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ProceedsFromIssuanceOfPrivatePlacement":{"label":"Proceeds from Issuance of Private Placement","description":"The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":602680,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":1058554,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-2192461,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":-3507007,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":-5478389,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":-10120611,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty":{"label":"Related Party Transaction, Expenses from Transactions with Related Party","description":"Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-12-31","val":15000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-12-31","val":7500,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020"},{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":7500,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"},{"start":"2021-01-01","end":"2021-12-31","val":7500,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":1085469,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":400738,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":1745446,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":659977,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":186981,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":95074,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":1313954,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":1126972,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-13800612,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2020-12-31","val":-13800612,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-06-30","val":-19279001,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-23921223,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":333333,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-09-30","val":508333,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-06-30","val":2411441,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-09-30","val":4482078,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).","units":{"USD/shares":[{"start":"2019-01-01","end":"2019-12-31","val":2.14,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2019-01-01","end":"2019-12-31","val":2.14,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2019"},{"start":"2020-01-01","end":"2020-12-31","val":2.14,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-12-31","val":2.14,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate","description":"The risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2021-04-01","end":"2021-06-30","val":0.0108,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":0.0109,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate","description":"Rate of weighted-average expected volatility for award under share-based payment arrangement.","units":{"pure":[{"start":"2021-04-01","end":"2021-06-30","val":0.93,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":0.93,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-04-01","end":"2021-06-30","val":807500,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":2357500,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2021-04-01","end":"2021-06-30","val":4.75,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":4.72,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2021-06-30","val":462000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":1569333,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2021-06-30","val":6.26,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2I"},{"end":"2021-09-30","val":6.2,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-06-30","val":6.26,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":6.26,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":4.72,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":6.21,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares","description":"Number of options vested.","units":{"shares":[{"start":"2021-04-01","end":"2021-06-30","val":345500,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":788167,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"SharesIssuedPricePerShare":{"label":"Shares Issued, Price Per Share","description":"Per share or per unit amount of equity securities issued.","units":{"USD/shares":[{"end":"2019-03-29","val":2,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2019-03-29","val":2,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2019Q1I"}]}},"StockGrantedDuringPeriodValueSharebasedCompensation":{"label":"Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture","description":"Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":166667,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-03-31","val":166667,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":166666,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":166666,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":175000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":191667,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-03-31","val":191667,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":2219774,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":2219774,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":2070637,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"StockholdersEquityNoteStockSplitConversionRatio1":{"label":"Stockholders' Equity Note, Stock Split, Conversion Ratio","description":"Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.","units":{"pure":[{"start":"2021-01-01","end":"2021-06-30","val":0.5,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"}]}},"StockIssuedDuringPeriodSharesConversionOfUnits":{"label":"Stock Issued During Period, Shares, Conversion of Units","description":"The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).","units":{"shares":[{"end":"2021-06-29","val":7041208,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2021-06-29","val":7041208,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2I"}]}},"StockIssuedDuringPeriodSharesNewIssues":{"label":"Stock Issued During Period, Shares, New Issues","description":"Number of new stock issued during the period.","units":{"shares":[{"end":"2021-06-29","val":2875000,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"end":"2021-06-29","val":2875000,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2I"}]}},"StockIssuedDuringPeriodValueConversionOfUnits":{"label":"Stock Issued During Period, Value, Conversion of Units","description":"Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).","units":{"USD":[{"start":"2021-04-01","end":"2021-06-30","val":0,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"}]}},"StockIssuedDuringPeriodValueIssuedForServices":{"label":"Stock Issued During Period, Value, Issued for Services","description":"Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":181100,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-01-01","end":"2020-03-31","val":181100,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":161096,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":161096,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":131645,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":135471,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-01-01","end":"2021-03-31","val":135471,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":37500,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":37500,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":1327270,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2021-04-01","end":"2021-06-30","val":14797132,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":14797132,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-06-30","val":5919792,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2020-04-01","end":"2020-06-30","val":5975971,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2020Q2"},{"start":"2021-01-01","end":"2021-06-30","val":6908396,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13"},{"start":"2021-04-01","end":"2021-06-30","val":6968341,"accn":"0001104659-21-105074","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-13","frame":"CY2021Q2"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":-0.58,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":-0.21,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-1.27,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":-0.46,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":-0.58,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":-0.21,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-1.27,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":-0.46,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"SellingGeneralAndAdministrativeExpense":{"label":"Selling, General and Administrative Expense","description":"The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":208270,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":6037254,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":6266584,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":7988563,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":10116403,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":6037254,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2020-07-01","end":"2020-09-30","val":6266584,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":7988563,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":10116403,"accn":"0001104659-21-138038","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}}}}}